撤回：促动力蛋白作为低级别胶质瘤的预后生物标志物：一项基于癌症基因组图谱数据的研究。
Retracted: Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
作者信息
International BioMed Research
出版信息
Biomed Res Int. 2024 Mar 20;2024:9848746. doi: 10.1155/2024/9848746. eCollection 2024.
Abstract
[This retracts the article DOI: 10.1155/2022/2309339.].
摘要
[本文撤回文章DOI: 10.1155/2022/2309339。]
相似文献
1
Retracted: Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.撤回：促动力蛋白作为低级别胶质瘤的预后生物标志物：一项基于癌症基因组图谱数据的研究。
Biomed Res Int. 2024 Mar 20;2024:9848746. doi: 10.1155/2024/9848746. eCollection 2024.
2
Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.胃动素原作为低级别胶质瘤的预后生物标志物：基于癌症基因组图谱数据的研究。
Biomed Res Int. 2022 Jul 7;2022:2309339. doi: 10.1155/2022/2309339. eCollection 2022.
3
Retracted: Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.撤回：滋养蛋白是骨肉瘤的重要生物标志物和预后因素：来自Oncomine和癌症基因组图谱数据库的数据挖掘
Biomed Res Int. 2024 Mar 20;2024:9834610. doi: 10.1155/2024/9834610. eCollection 2024.
4
Retracted: Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas.撤回：基于癌症基因组图谱数据鉴定9种与m6A相关的长链非编码RNA作为口腔癌氧化应激相关的预后标志物。
Oxid Med Cell Longev. 2023 Dec 29;2023:9796081. doi: 10.1155/2023/9796081. eCollection 2023.
5
Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.撤稿：低剂量阿帕替尼改善复发性高级别胶质瘤患者的预后。
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9853753. doi: 10.1155/2023/9853753. eCollection 2023.
6
Retracted: DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.撤回：DNM1：一种与结肠癌免疫浸润相关的预后生物标志物——基于TCGA数据库的研究
Biomed Res Int. 2024 Mar 20;2024:9824604. doi: 10.1155/2024/9824604. eCollection 2024.
7
CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.CKS2（CDC28 蛋白激酶调节亚基 2）是低级别胶质瘤的预后生物标志物：基于生物信息学分析和免疫组织化学的研究。
Bioengineered. 2021 Dec;12(1):5996-6009. doi: 10.1080/21655979.2021.1972197.
8
Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer.撤回：IL2RB 是一种与泛癌免疫浸润相关的预后生物标志物。
J Oncol. 2023 Nov 1;2023:9807856. doi: 10.1155/2023/9807856. eCollection 2023.
9
Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer.撤回：miR-451和miR-506作为乳腺癌患者预后生物标志物的临床潜力。
J Healthc Eng. 2023 Aug 16;2023:9870383. doi: 10.1155/2023/9870383. eCollection 2023.
10
Retracted: HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.撤回：HHLA2作为一种潜在的预后和免疫生物标志物及其与泛癌肿瘤微环境的相关性
Biomed Res Int. 2024 Mar 20;2024:9789013. doi: 10.1155/2024/9789013. eCollection 2024.
本文引用的文献
1
Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.胃动素原作为低级别胶质瘤的预后生物标志物：基于癌症基因组图谱数据的研究。
Biomed Res Int. 2022 Jul 7;2022:2309339. doi: 10.1155/2022/2309339. eCollection 2022.
Zotero 插件